In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $433.00. The company’s shares ...

Vertex Pharmaceuticals (VRTX) Incorporated announced that the U.S. Food and Drug Administration has approved JOURNAVX, an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the ...

DeepSeek released its buzziest large language model, R1, on Jan. 20. The AI assistant hit No. 1 on the Apple App Store in recent days, bumping OpenAI’s long-dominant ChatGPT down to No. 2.

Please view our affiliate disclosure. But that's where Turbologo steps in. It's an AI logo maker designed to help you effortlessly create a professional logo in minutes! In this Turbologo review, I'll ...

DeepSeek is quickly shaking up the state of AI in the US, but while several of Apple’s competitors deal with negative fallout, Apple is—for now at least—benefiting from DeepSeek in three ways.

Tech stocks plunged Monday morning as fears mounted that Chinese artificial intelligence firm DeepSeek is gaining U.S. dominance in AI development. NBC News’ Brian Cheung reports on what ...

ForbesFive Reasons Why Developers Love DigitalOceanBy Janakiram MSV In comparison to competitors like Amazon Bedrock, Microsoft Azure AI or Google Vertex AI, DigitalOcean’s platform offers a ...

Wall Street’s superstars are tumbling as a competitor from China threatens to upend the artificial-intelligence frenzy that has created a spending bonanza. The S&P 500 was down 1.7 percent in ...

Welcome to 9to5Neural. AI moves fast. We help you keep up. Last week we mentioned that American AI firms are seeing deep competition from DeepSeek R1 out of China. Today DeepSeek’s impact has ...

Now the digital revolution is being overtaken by the AI revolution. And this time the speed, scale, and scope of industrial transformation will dwarf previous upheavals. According to our economic ...